Colorectal cancer and adenoma screening using urinary volatile organic compound (VOC) detection: early results from a single-centre bowel screening population (UK BCSP)

Monitoring of selected skin- and breath-borne volatile organic compounds emitted from the human body using gas chromatography ion mobility spectrometry (GC-IMS)

(2018) Paweł Mochalski et al.   JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES

Critical research gaps and recommendations to inform research prioritisation for more effective prevention and improved outcomes in colorectal cancer

(2017) Mark Lawler et al.   GUT

Volatile organic compounds as new biomarkers for colorectal cancer: a review

(2016) M. Di Lena et al.   Colorectal Disease

Non-invasive exhaled volatile organic biomarker analysis to detect inflammatory bowel disease (IBD)

(2016) Ramesh P. Arasaradnam et al.   DIGESTIVE AND LIVER DISEASE

Volatile organic compounds in plasma for the diagnosis of esophageal adenocarcinoma: a pilot study

(2016) Amit Bhatt et al.   GASTROINTESTINAL ENDOSCOPY

UK key performance indicators and quality assurance standards for colonoscopy

(2016) Colin J Rees et al.   GUT

Application and Uses of Electronic Noses for Clinical Diagnosis on Urine Samples: A Review

(2016) Laura Capelli et al.   SENSORS

The use of the PEN3 e-nose in the screening of colorectal cancer and polyps

(2016) D. F. Altomare et al.   Techniques in Coloproctology

The application of FAIMS gas analysis in medical diagnostics

(2015) J. A. Covington et al.   ANALYST

Development and application of a new electronic nose instrument for the detection of colorectal cancer

(2015) E. Westenbrink et al.   BIOSENSORS & BIOELECTRONICS

Faecal immunochemical tests versus guaiac faecal occult blood tests: what clinicians and colorectal cancer screening programme organisers need to know

(2015) Jill Tinmouth et al.   GUT

Breath testing as potential colorectal cancer screening tool

(2015) Haitham Amal et al.   INTERNATIONAL JOURNAL OF CANCER

Carcinogenicity of consumption of red and processed meat

(2015) Véronique Bouvard et al.   LANCET ONCOLOGY

Use of the Analysis of the Volatile Faecal Metabolome in Screening for Colorectal Cancer

(2015) Claire A Batty et al.   PLoS One

Fecal volatile organic compounds: a novel, cheaper method of diagnosing inflammatory bowel disease?

(2014) Chris SJ Probert et al.   Expert Review of Clinical Immunology

Detection of Colorectal Cancer (CRC) by Urinary Volatile Organic Compound Analysis

(2014) Ramesh P. Arasaradnam et al.   PLoS One

Differentiating Coeliac Disease from Irritable Bowel Syndrome by Urinary Volatile Organic Compound Analysis – A Pilot Study

(2014) Ramesh P. Arasaradnam et al.   PLoS One

Assessment, origin, and implementation of breath volatile cancer markers

(2013) Hossam Haick et al.   CHEMICAL SOCIETY REVIEWS

Electronic nose can discriminate colorectal carcinoma and advanced adenomas by fecal volatile biomarker analysis: proof of principle study

(2013) Tim G. de Meij et al.   INTERNATIONAL JOURNAL OF CANCER

Noninvasive analysis of volatile biomarkers in human emanations for health and early disease diagnosis

(2013) Hiroyuki Kataoka et al.   Bioanalysis

Metabolomics Study on the Biochemical Profiles of Odor Elements in Urine of Human with Bladder Cancer

(2012) Kohei Jobu et al.   BIOLOGICAL & PHARMACEUTICAL BULLETIN

Exhaled volatile organic compounds identify patients with colorectal cancer

(2012) D. F. Altomare et al.   BRITISH JOURNAL OF SURGERY

Clinical use of exhaled volatile organic compounds in pulmonary diseases: a systematic review

(2012) Kim DG van de Kant et al.   RESPIRATORY RESEARCH

The Detection of Patients at Risk of Gastrointestinal Toxicity during Pelvic Radiotherapy by Electronic Nose and FAIMS: A Pilot Study

(2012) James A. Covington et al.   SENSORS

Outcomes of the Bowel Cancer Screening Programme (BCSP) in England after the first 1 million tests

(2011) Richard F A Logan et al.   GUT

Solid phase microextraction, mass spectrometry and metabolomic approaches for detection of potential urinary cancer biomarkers—A powerful strategy for breast cancer diagnosis

(2011) Catarina L. Silva et al.   TALANTA

Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002)

(2010) S. R. Cairns et al.   GUT